Hormos Medical Corporation

Hormos Nutraceutical Oy Ltd.

Helena Korte

Markku Ahotupa

Mikko Unkila

Lauri V Kangas

Arja Marketta Kalapudas

John E Eriksson

Seppo Parhi

Veli-Matti Lehtola

Mervi Puska

Mervi Hiilovaara-Teijo

Petri Hukka

Janne Komi

Merja Perälä

A topical formulation which includes a lignan or lignan ester in a dermatologically acceptable vehicle. The formulation can be either a cosmetic formulation or a pharmaceutical formulation.

Lignan formulations

A method for the production of hydroxymatairesinol or a hydroxymatairesinol complex from wood, including the steps of a) extracting finely divided wood material with a polar solvent, b) optionally concentrating the extract by separating at least part of the solvent, c) adding to the extract an agent able to form a complex with hydroxymatairesinol, d) precipitating the hydroxymatairesinol complex, and optionally e) releasing the hydroxymatairesinol from the complex.

Method for the production of a phenolic substance from wood

The invention relates to a method of inhibiting myeloperoxidase activity in neutrophils in an individual by administering to the individual an effective amount of a lignan, where said lignan is enterolactone. The invention is further directed to a method inhibiting myeloperoxidase activity or oxidative burst of macrophages in an individual by administering to the individual an effective amount of a lignan where said lignan is enterolactone or hydroxymatairesinol or a mixture. Finally, the invention is directed to a method of inhibiting oxidative burst or myeloperoxidase activity in neutrophils in an individual by administering to the individual an effective amount of a lignan which is hydroxymatairesinol.

Method of inhibiting overactivity of phagocytes or lymphocytes in an individual

Growing community of inventors

Turku, Finland

Helena Korte